Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?

Philip G. Tibbo; Kyle A. McKee; Jeffrey H. Meyer; Candice E. Crocker; Katherine J. Aitchison; Raymond W. Lam; David N. Crockford

doi:10.1177/0706743720945525

Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?

Philip G. Tibbo, Kyle A. McKee, Jeffrey H. Meyer, Candice E. Crocker, Katherine J. Aitchison, Raymond W. Lam, David N. Crockford

Research output: Contribution to journal › Comment/debate › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	185-194
Number of pages	10
Journal	Canadian Journal of Psychiatry
Volume	66
Issue number	2
DOIs	https://doi.org/10.1177/0706743720945525
Publication status	Published - Feb 2021
Externally published	Yes

ASJC Scopus Subject Areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/0706743720945525

Cite this

@article{ba61fd7f0d5e4333a0c8642127b9d0f8,

title = "Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?",

author = "Tibbo, {Philip G.} and McKee, {Kyle A.} and Meyer, {Jeffrey H.} and Crocker, {Candice E.} and Aitchison, {Katherine J.} and Lam, {Raymond W.} and Crockford, {David N.}",

note = "Publisher Copyright: {\textcopyright} Canadian Psychiatric Association 2020.",

year = "2021",

month = feb,

doi = "10.1177/0706743720945525",

language = "English",

volume = "66",

pages = "185--194",

journal = "Canadian Journal of Psychiatry",

issn = "0706-7437",